EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Epigenetics as a Therapeutic Target in Osteoarthritis

Carmen Núñez-Carro iD, Margarita Blanco-Blanco iD, Karla Mariuxi Villagrán-Andrade, Francisco J Blanco iD, María C de Andrés iD

Pharmaceuticals · 21.01.2023 · 16 (2) · 156

DOI: 10.3390/ph16020156 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 21.01.2023. Verfasst von Carmen Núñez-Carro und 4 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Epigenética, Grupo de Investigación en Reumatología (GIR), Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario…. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Xunta de Galicia, European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis (OA) is a heterogenous, complex disease affecting the integrity of diarthrodial joints that, despite its high prevalence worldwide, lacks effective treatment. In recent years it has been discovered that epigenetics may play an important role in OA. Our objective is to review the current knowledge of the three classical epigenetic mechanisms—DNA methylation, histone post-translational modifications (PTMs), and non-coding RNA (ncRNA) modifications, including microRNAs (miRNAs), circular RNAs (circRNAs), and long non-coding RNAs (lncRNAs)—in relation to the pathogenesis of OA and focusing on articular cartilage. The search for updated literature was carried out in the PubMed database. Evidence shows that dysregulation of numerous essential cartilage molecules is caused by aberrant epigenetic regulatory mechanisms, and it contributes to the development and progression of OA. This offers the opportunity to consider new candidates as therapeutic targets with the potential to attenuate OA or to be used as novel biomarkers of the disease.

Schlagwörter

Stichwörter der Autor:innen

DNA methylationcircRNAepigeneticshistone acetylationhistone methylationlncRNAmiRNAosteoarthritis

Autor:innen und Institutionen

  • Unidad de Epigenética, Grupo de Investigación en Reumatología (GIR), Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario, de A Coruña (CHUAC), Sergas, 15006 A Coruña, Spain.
  • Grupo de Investigación en Reumatología y Salud, Departamento de Fisioterapia, Medicina y Ciencias Biomédicas, Facultad de Fisioterapia, Campus de Oza, Universidade da Coruña (UDC), 15008 A Coruña, Spain.

ORCID-Profile: Carmen Núñez-Carro, Margarita Blanco-Blanco, Francisco J Blanco, María C de Andrés

Förderung

  • Instituto de Salud Carlos III
  • Xunta de Galicia
  • European Union
  • Fondo Investigación Sanitaria-Spain

Zitieren

APA

Núñez-Carro, C., Blanco-Blanco, M., Villagrán-Andrade, K. M., Blanco, F. J., & de Andrés, M. C. (2023). Epigenetics as a Therapeutic Target in Osteoarthritis. Pharmaceuticals, 16(2), 156. https://doi.org/10.3390/ph16020156

Vancouver

Núñez-Carro C, Blanco-Blanco M, Villagrán-Andrade KM, Blanco FJ, de Andrés MC. Epigenetics as a Therapeutic Target in Osteoarthritis. Pharmaceuticals. 2023;16(2):156. doi:10.3390/ph16020156

BibTeX
@article{NezCarro2023,
  author = {Núñez-Carro, Carmen and Blanco-Blanco, Margarita and Villagrán-Andrade, Karla Mariuxi and Blanco, Francisco J and de Andrés, María C},
  title = {Epigenetics as a Therapeutic Target in Osteoarthritis},
  journal = {Pharmaceuticals},
  year = {2023},
  volume = {16},
  number = {2},
  pages = {156},
  doi = {10.3390/ph16020156}
}
Kostenlos starten →